Helical closes $10M seed to turn bio foundation models into systems

Helical's closure of a $10M seed round to turn bio foundation models into systems, led by redalpine and backed by angel investors including the CEOs of Cohere and HuggingFace, marks a significant investment in the application of AI in the pharmaceutical industry. This development has significant implications for website owners in the pharmaceutical and healthcare sectors, as it may lead to increased AI bot traffic from companies like Pfizer, which is already collaborating with Helical. As bio foundation models become more integrated into pharmaceutical systems, website owners may see a rise in AI-generated queries and interactions, potentially impacting their site's traffic and content engagement. To prepare for this shift, website owners can take several actionable steps: first, review and update their llms.txt files to ensure they are accurately tracking AI bot traffic from pharmaceutical companies; second, consider implementing AI-content detection tools to identify and respond to AI-generated queries; and third, monitor their site's analytics to understand how AI bot traffic is impacting their online presence and adjust their content strategies accordingly.